The DOI matches its Crossref record; 283 of the 283 references it cites were found in a registry or an index.
Myeloid Cell-Derived Arginase in Cancer Immune Response
Open accessAbstract
Amino acid metabolism is a critical regulator of the immune response, and its modulating becomes a promising approach in various forms of immunotherapy. Insufficient concentrations of essential amino acids restrict T-cells activation and proliferation. However, only arginases, that degrade L-arginine, as well as enzymes that hydrolyze L-tryptophan are substantially increased in cancer. Two arginase isoforms, ARG1 and ARG2, have been found to be present in tumors and their increased activity usually correlates with more advanced disease and worse clinical prognosis. Nearly all types of myeloid cells were reported to produce arginases and the increased numbers of various populations of myeloid-derived suppressor cells and macrophages correlate with inferior clinical outcomes of cancer patients. Here, we describe the role of arginases produced by myeloid cells in regulating various populations of immune cells, discuss molecular mechanisms of immunoregulatory processes involving L-arginine metabolism and outline therapeutic approaches to mitigate the negative effects of arginases on antitumor immune response. Development of potent arginase inhibitors, with improved pharmacokinetic properties, may lead to the elaboration of novel therapeutic strategies based on targeting immunoregulatory pathways controlled by L-arginine degradation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–283 of 283
Mussai, F., Egan, S. A., Hunter, S., Webber, H. T., Fisher, J. P. H., Wheat, R. L., McConville, C. M., Sbirkov, Y., Wheeler, K., Bendle, G. M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3443 · Cited by 115
Ma, P., Beatty, P. L., McKolanis, J., Brand, R. E., Schoen, R. E., & Finn, O. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01401 · Cited by 115
de Jonge, W. J., Kwikkers, K. L., Velde, A. A. T., van Deventer, S. J. H., Nolte, M. A., Mebius, R. E., Ruijter, J. M., Lamers, M. C., & Lamers, W. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16143 · Cited by 113
Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
DeVito, N. C., Plebanek, M. P., Theivanthiran, B., & Hanks, B. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02876 · Cited by 113
Líndez, A.-A. M. I., Dunand-Sauthier, I., Conti, M., Gobet, F., Núñez, N. G., Hannich, J. T., Riezman, H., Geiger, R., Piersigilli, A., Hahn, K., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.132975 · Cited by 111
Sin, Y. Y., Baron, G., Schulze, A., & Funk, C. D. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1354-3 · Cited by 109
Yau, T. C. C., Cheng, P. N.-M., Chan, P., Chan, W., Chen, L., Yuen, J. H. F., Pang, R. W. C., Fan, S. T., & Poon, R. T. P. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9807-9 · Cited by 109
Choi, B.-S., Martinez-Falero, I. C., Corset, C., Munder, M., Modolell, M., Müller, I., & Kropf, P. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0508310 · Cited by 107
Liu, Y., Ginderachter, J. A. V., Brys, L., BAETSELIER, P. D., Raes, G., & Geldhof, A. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5064 · Cited by 104
Chaturvedi, R., Asim, M., Hoge, S., Lewis, N. D., Singh, K., Barry, D. P., de Sablet, T., Piazuelo, M. B., Sarvaria, A. R., Cheng, Y., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.060 · Cited by 104
Cofilin peptide homologs interfere with immunological synapse formation and T cell activation
Eibert, S. M., Lee, K., Pipkorn, R., Sester, U., Wabnitz, G. H., Giese, T., Meuer, S. C., & Samstag, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308282100 · Cited by 103
de Jonge, W. J., Kwikkers, K. L., Velde, A. A. T., van Deventer, S. J. H., Nolte, M. A., Mebius, R. E., Ruijter, J. M., Lamers, M. C., & Lamers, W. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216143 · Cited by 103
Soncin, I., Sheng, J., Chen, Q., Foo, S., Duan, K., Lum, J., Poidinger, M., Zolezzi, F., Karjalainen, K., & Ruedl, C. (2018) · Nature Communications · doi:10.1038/s41467-018-02834-8 · Cited by 102
Regulatory Interactions Between Neutrophils, Tumor Cells and T Cells
Oberg, H., Wesch, D., Kalyan, S., & Kabelitz, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01690 · Cited by 102
García‐Navas, R., Munder, M., & Mollinedo, F. (2012) · Autophagy · doi:10.4161/auto.21315 · Cited by 99
Microenvironmental arginine depletion by macrophages in vivo
Currie, G. A., Gyure, L. A., & Cifuentes, L. (1979) · British Journal of Cancer · doi:10.1038/bjc.1979.112 · Cited by 96
Neamah, W. H., Singh, N. P., Alghetaa, H., Abdulla, O. A., Chatterjee, S., Busbee, P. B., Nagarkatti, M., & Nagarkatti, P. S. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900291 · Cited by 94
Rodríguez, P. C., Hernandez, C. P., Morrow, K. D., Sierra, R. A., Zabaleta, J., Wyczechowska, D. D., & Ochoa, A. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001224 · Cited by 93
Berry, R. S., Xiong, M.-J., Greenbaum, A. A., Mortaji, P., Nofchissey, R. A., Schultz, F. A., Martinez, C. G., Luo, L., Morris, K. T., & Hanson, J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188799 · Cited by 92
Arginase and autoimmune inflammation in the central nervous system
Xu, L., Hilliard, B. A., Carmody, R. J., Tsabary, G., Shin, H., Christianson, D. W., & Chen, Y. H. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01713.x · Cited by 90
Haskó, G., Kuhel, D. G., Marton, A., Németh, Z. H., Deitch, E. A., & Szabó, C. (2000) · Shock · doi:10.1097/00024382-200014020-00012 · Cited by 90
Elpek, K. G., Cremasco, V., Shen, H., Harvey, C. J., Wucherpfennig, K. W., Goldstein, D. R., Monach, P. A., & Turley, S. J. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0209 · Cited by 89
Keeley, T. S., Costanzo-Garvey, D. L., & Cook, L. M. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.10.013 · Cited by 88
Werner, A., Amann, E., Schnitzius, V., Habermeier, A., Luckner‐Minden, C., Leuchtner, N., Rupp, J., Closs, E. I., & Munder, M. (2015) · European Journal of Immunology · doi:10.1002/eji.201546047 · Cited by 86
Arginine deficiency leads to impaired cofilin dephosphorylation in activated human T lymphocytes
Feldmeyer, N., Wabnitz, G. H., Leicht, S., Luckner‐Minden, C., Schiller, M. R., Franz, T., Conradi, R., Kropf, P., Müller, I., Ho, A. D., et al. (2012) · International Immunology · doi:10.1093/intimm/dxs004 · Cited by 86
Lüneburg, N., Xanthakis, V., Schwedhelm, E., SULLIVAN, L. M., Maas, R., Anderssohn, M., Riederer, U., Glazer, N. L., Vasan, R. S., & Böger, R. H. (2011) · Journal of Nutrition · doi:10.3945/jn.111.148197 · Cited by 86
Immune Evasion by Helicobacter pylori Is Mediated by Induction of Macrophage Arginase II
Lewis, N. D., Asim, M., Barry, D. P., de Sablet, T., Singh, K., Piazuelo, M. B., Gobert, A. P., Chaturvedi, R., & Wilson, K. T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003431 · Cited by 83
Dizikes, G. J., Grody, W. W., Kern, R. M., & Cederbaum, S. D. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80333-3 · Cited by 83
Zhang, J., Xu, X., Shi, M., Chen, Y., Yu, D., Zhao, C., Gu, Y., Yang, B., Guo, S., Ding, G., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1258504 · Cited by 83
Inhibition of human arginase I by substrate and product analogues
Costanzo, L. D., Ilies, M., Thorn, K. J., & Christianson, D. W. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.02.004 · Cited by 81
The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma
You, J., Chen, W., Chen, J., Zheng, Q., Dong, J., & Zhu, Y. (2018) · BioMed Research International · doi:10.1155/2018/2109865 · Cited by 80
Yau, T. C. C., Cheng, P., Chan, P., Chen, L., Yuen, J. H. F., Pang, R. W. C., Fan, S. T., Wheatley, D. N., & Poon, R. T. P. (2015) · Investigational New Drugs · doi:10.1007/s10637-014-0200-8 · Cited by 79
Dunand-Sauthier, I., Irla, M., Carnésecchi, S., Seguín-Estévez, Q., Vejnar, C. E., Zdobnov, E. M., Santiago‐Raber, M., & Reith, W. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301913 · Cited by 78
Arginase in patients with breast cancer
Porembska, Z., Luboiński, G., Chrzanowska, A., Mielczarek‐Puta, M., Magnuska, J., & Barańczyk‐Kuźma, A. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00391-1 · Cited by 77
Tsui, S. M., Lam, W.-M., Lam, T. L., Chong, H.-C., So, P., Kwok, S.-Y., Arnold, S., Cheng, P. N.-M., Wheatley, D. N., Lo, W., et al. (2009) · Cancer Cell International · doi:10.1186/1475-2867-9-9 · Cited by 76
Sayed, M. F. A., Amrein, M. A., Bührer, E. D., Huguenin, A.-L., Radpour, R., Riether, C., & Ochsenbein, A. F. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3026 · Cited by 74
Myeloid-derived suppressor cells modulate B-cell responses
Lelis, F., Jaufmann, J., Singh, A., Fromm, K., Teschner, A. C., Pöschel, S., Schäfer, I., Beer‐Hammer, S., Rieber, N. P., & Hartl, D. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.07.003 · Cited by 73
LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression
Chai, E., Zhang, L., & Li, C. (2019) · Cancer Management and Research · doi:10.2147/cmar.s210545 · Cited by 73
Orecchioni, M., Ghosheh, Y., Pramod, A. B., & Ley, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00234 · Cited by 71
Immunomodulatory Roles of Cell Cycle Regulators
Laphanuwat, P., & Jirawatnotai, S. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00023 · Cited by 71
Mao, F.-Y., Zhao, Y., Lv, Y.-P., Teng, Y., Kong, H., Liu, Y., Wu, X., Hao, C.-J., Chen, W., Duan, M., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0803-7 · Cited by 71
Elevated Serum Arginase Activity Levels in Patients with Breast Cancer
Polat, M. F., Tayşi, S., Polat, S., B�y�k, A., & Bakan, E. (2003) · Surgery Today · doi:10.1007/s00595-002-2563-2 · Cited by 67
Baggio, R., Emig, F. A., Christianson, D. W., Ash, D. E., Chakder, S., & Rattan, S. C. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35048-7 · Cited by 65
Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer
Ma, Z., Lian, J., Yang, M., Wuyang, J., Zhao, C., Chen, W., Liu, C., Zhao, Q., Lou, C., Han, J., et al. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.03.012 · Cited by 65
Chang, J., Thangamani, S., Kim, M. H., Ulrich, B. J., Morris, S. M., & Kim, C. H. (2013) · European Journal of Immunology · doi:10.1002/eji.201242772 · Cited by 63
Human Embryonic Stem Cells Suppress T Cell Responses via Arginase I-Dependent Mechanism
Yachimovich‐Cohen, N., Even‐Ram, S., Shufaro, Y., Rachmilewitz, J., & Reubinoff, B. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804261 · Cited by 63
Androgen-Regulated Expression of Arginase 1, Arginase 2 and Interleukin-8 in Human Prostate Cancer
Gannon, P. O., Godin-Ethier, J., Hassler, M. R., Delvoye, N., Aversa, M. M., Poisson, A. O., Péant, B., Fahmy, M. A., Fred Saad, C., Lapointe, R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012107 · Cited by 63
Secondini, C., Coquoz, O., Spagnuolo, L., Spinetti, T., Peyvandi, S., Ciarloni, L., Botta, F., Bourquin, C., & Rüegg, C. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1316437 · Cited by 63
Ammonium Metabolism Enzymes Aid Helicobacter pylori Acid Resistance
Miller, E. F., & Maier, R. J. (2014) · Journal of Bacteriology · doi:10.1128/jb.01423-13 · Cited by 59
Jost, M. M., Ninci, E., Meder, B., Kempf, C., van Royen, N., Hua, J., Berger, B. J., Hoefer, I. E., Modolell, M., & Buschmann, I. R. (2003) · The FASEB Journal · doi:10.1096/fj.03-0071fje · Cited by 59
The role of arginase in the immune response
Schneider, E., & Dy, M. (1985) · Immunology Today · doi:10.1016/0167-5699(85)90081-7 · Cited by 58
Arginase and ornithine, as markers in human non-small cell lung carcinoma.
Gökmen, S. S., Yörük, Y., Cakir, E., Yorulmaz, F., & Gülen, Ş. (1999) · PubMed · Cited by 56
The Role of Arginase 1 in Post-Stroke Immunosuppression and Ischemic Stroke Severity
Petrone, A. B., O’Connell, G. C., Regier, M., Chantler, P. D., Simpkins, J. W., & Barr, T. L. (2015) · Translational Stroke Research · doi:10.1007/s12975-015-0431-9 · Cited by 56
Characterization of the Arginine Deiminase Operon of Streptococcus rattus FA-1
Griswold, A. R., Chen, Y. M., Snyder, J. A., & Burne, R. A. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.3.1321-1327.2004 · Cited by 53
Yang, Q., Wei, J., Zhong, L., Shi, M., Zhou, P., Zuo, S., Wu, K., Zhu, M., Huang, X., Yu, Y., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00805-14 · Cited by 53
Werner, A., Pieh, D., Echchannaoui, H., Rupp, J., Rajalingam, K., Theobald, M., Closs, E. I., & Munder, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01268 · Cited by 53
Sippel, T. R., Shimizu, T., Strnad, F. A., Traystman, R. J., Herson, P. S., & Waziri, A. E. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.103 · Cited by 52
Significance of arginase and ornithine in malignant tumors of the human skin
Gökmen, S. S., AYGIT, A. C., Ayhan, M. S., Yorulmaz, F., & Gülen, Ş. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.114543 · Cited by 52
Ashley, J. W., Hancock, W. D., Nelson, A. J., Bone, R. N., Tse, H. M., Wohltmann, M., TURK, J. W., & Ramanadham, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.754945 · Cited by 50
Inducible Arginase 1 Deficiency in Mice Leads to Hyperargininemia and Altered Amino Acid Metabolism
Sin, Y. Y., Ballantyne, L. L., Mukherjee, K., Amand, T. S., Kyriakopoulou, L. G., Schulze, A., & Funk, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080001 · Cited by 48
Discovery and Pharmacokinetics of Sulfamides and Guanidines as Potent Human Arginase 1 Inhibitors
Błaszczyk, R., Brzezinska, J., Dymek, B., Stańczak, P. S., Mazurkiewicz, M., Olczak, J., Nowicka, J., Dzwonek, K., Zagożdżon, A., Gołąb, J., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00508 · Cited by 46
Rotondo, R., Mastracci, L., Piazza, T., Barisione, G., Fabbi, M., Cassanello, M., Costa, R., Morandi, B., Astigiano, S., Cesario, A., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23437 · Cited by 45
Suwanpradid, J., Shih, M., Pontius, L. N., Yang, B., Birukova, A., Guttman‐Yassky, E., Corcoran, D. L., Que, L. G., Tighe, R. M., & MacLeod, A. S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700739 · Cited by 45
Arginase-II Deficiency Extends Lifespan in Mice
Xiong, Y., Yepuri, G., Montani, J., Ming, X., & Yang, Z. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00682 · Cited by 42
Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors
Abdelkawy, K. S., Lack, K., & Elbarbry, F. (2016) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-016-0381-y · Cited by 40
Rouzaut, A., Subirá, M. L., de Miguel, C., Miguel, E. D. D., González, A., Santiago, E., & López-Moratalla, N. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(99)00106-8 · Cited by 39
Chen, F., Lucas, R., & Fulton, D. J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00184 · Cited by 38
Human monocytic myeloid‐derived suppressor cells impair B‐cell phenotype and function in vitro
Jaufmann, J., Lelis, F., Teschner, A. C., Fromm, K., Rieber, N. P., Hartl, D., & Beer‐Hammer, S. (2019) · European Journal of Immunology · doi:10.1002/eji.201948240 · Cited by 38
Corraliza, I., Modolell, M., Ferber, E., & Soler, G. (1997) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(96)00081-5 · Cited by 37
Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse
Kasten, J., Hu, C., Bhargava, R., Park, H., Tai, D. S., Byrne, J., Marescau, B., Deyn, P. P. D., Schlichting, L., Grody, W. W., et al. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.06.020 · Cited by 33
Yu, H., Tsai, C., Chang, L., Huang, H.-C., Cheng, H.-H., Wang, J., Sheen, J., Kuo, H., Hsieh, K., Huang, Y., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00487 · Cited by 32
de Velde, L.-A. V., & Murray, P. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.c116.763623 · Cited by 31
Single cell behavior in T cell differentiation
Rohr, J., Gerlach, C., Kok, L., & Schumacher, T. N. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.02.006 · Cited by 30
Immunosuppression in cervical cancer with special reference to arginase activity
Bedoya, A. M., Tate, D. J., Baena, A., Córdoba, C. M., Borrero, M., Pareja, R., Rojas, F., Patterson, J. R., Herrero, R., Zea, A. H., et al. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.07.096 · Cited by 29
Tong, Y., Zhou, L., Yang, L., Guo, P., Cao, Y., Qin, F. X.-F., & Liu, J. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.062 · Cited by 26
Ballantyne, L. L., Sin, Y. Y., Al-Dirbashi, O. Y., Li, X., Hurlbut, D. J., & Funk, C. D. (2016) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2016.10.003 · Cited by 25
Arginase expression in mouse embryonic development
Yu, H., Iyer, R. K., Yoo, P. K., et al. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00089-8 · Cited by 23
Modulation of lymphocyte proliferation by enzymes that degrade amino acids
Chuang, J.-L., YU, C. L., & WANG, S. R. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb05473.x · Cited by 22
ENGELEN, M. P. K. J., Klimberg, V. S., Allasia, A., & Deutz, N. E. P. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.07.019 · Cited by 16
Eldredge, L. C., Creasy, R. S., Tanaka, S., Lai, J.-F., & Ziegler, S. F. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801374 · Cited by 16
Obiorah, I. E., Chahine, J. J., Ko, K., Park, B. U., deGuzman, J., & Kallakury, B. (2019) · Gastroenterology Research · doi:10.14740/gr1156 · Cited by 15
Saligan, L. N., Lukkahatai, N., Zhang, Z. J., Cheung, C. W., & Wang, X. M. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000454 · Cited by 13
Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer's Disease?
Ovsepian, S. V., & O’Leary, V. B. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0668-6 · Cited by 12
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
Metabolic barriers to cancer immunotherapy
DePeaux, K., & Delgoffe, G. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00541-y · Cited by 597
Interferon-γ: teammate or opponent in the tumour microenvironment?
Gocher, A. M., Workman, C. J., & Vignali, D. A. A. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00566-3 · Cited by 582
Myeloid-derived suppressor cells in cancer and cancer therapy
Lasser, S. A., Ozbay Kurt, F. G., Arkhypov, I., Utikal, J., & Umansky, V. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00846-y · Cited by 489
Arginine-dependent immune responses
Martí i Líndez, A.-A., & Reith, W. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03828-4 · Cited by 354
Metadata
- Authors
- Grzywa, T. M., Sosnowska, A., Matryba, P., Rydzynska, Z., Jasinski, M., Nowis, D., & Golab, J.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-05-15
- Volume
- 11
- Pages
- 938-938
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3024126283
- Cited by
- 424
- References
- 283
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.